schedule a meeting with a representative

visit the conference website

POSTER PRESENTATIONS

1

Poster #1322P REAL-WORLD TREATMENT PATTERNS AND IMMUNOTHERAPY (IO) SEQUENCING BASED ON PD-L1 TPS IN EUROPEAN PATIENTS WITH METASTATIC NSCLC

Speakers: Janowicz E, Ognar RG, Capart P, Stoyanov N, Nguyen B, Combest A, Anderson DJC
Date: Thursday, September 17, 2020

2

Poster #1340P REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH ADVANCED, ALK + NON-SMALL CELL LUNG CANCER (NSCLC) IN EUROPE

Speakers: Stoyanov N, Combest A, Nguyen B, Ognar R, Reitsma D, Capart P, Anderson DJC
Date: Thursday, September 17, 2020

3

Poster #627P REAL-WORLD EVIDENCE (RWE) FOR PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH CABAZITAXEL (CBZ): COMPARISON WITH THE RANDOMIZED CLINICAL STUDY CARD

Speakers: de Wit R, Feedland S, Oudard S, Marinov G, Capart P, Combest A, Peterson R, Ozatilgan A, Morgans A
Date: Thursday, September 17, 2020

PPD WEBINAR

Advancing Early Stage Oncology Research with Adaptive Designs and Master Protocols

Date: Tuesday, September 29, 2020 | 10:00 am EDT

Speakers:

Jurgen Hummel, MSc, Senior Director of Statistical Science, Biostatistics, PPD
Dirk Reitsma, MD, Vice President and Therapeutic Area Head, Oncology, Global Product Development, PPD

To be discussed:

Improved determination of the maximum tolerated dose, comparing different designs for dose selection
Advantages of basket trial design for finding the most appropriate indication(s)
Current regulatory positions and outlook of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human use (ICH)
Operational implications of different designs

Learn More about our oncology team